COSCIENS Biopharma Inc. (TSX:CSCI)

COSCIENS Biopharma Revenue

In the year 2025, COSCIENS Biopharma had annual revenue of $7.50M USD, down -21.79%. COSCIENS Biopharma had revenue of $1.77M in the quarter ending December 31, 2025, a decrease of -46.84%.

• Revenue: $7.50M
• Revenue Growth: -21.79%
• P/S Ratio: 0.83
• Revenue / Employee: $267.79K
• Employees: 28
• Market Cap: 8.57M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.50M	-2.09M	-21.79%
Dec 31, 2024	9.59M	2.44M	34.22%
Dec 31, 2023	7.14M	-7.43M	-50.98%
Dec 31, 2022	14.57M	9.31M	177.03%
Dec 31, 2021	5.26M	1.61M	44.03%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error